The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B

Por Tang, Hong, Griffin, Jamie, Innaimo, Steven, Lehman-Mckeeman, Lois, Llamoso, Cyril
Publicado no J Clin Transl Hepatol (2013)

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

Por Innaimo, S F, Seifer, M, Bisacchi, G S, Standring, D N, Zahler, R, Colonno, R J
Publicado em 1997

Metabolic Studies on BMS-200475, a New Antiviral Compound Active against Hepatitis B Virus

Por Yamanaka, Gregory, Wilson, Todd, Innaimo, Steven, Bisacchi, Gregory S., Egli, Peter, Rinehart, J. Kent, Zahler, Robert, Colonno, Richard J.
Publicado em 1999

Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection

Por Genovesi, E. V., Lamb, L., Medina, I., Taylor, D., Seifer, M., Innaimo, S., Colonno, R. J., Standring, D. N., Clark, J. M.
Publicado em 1999

Efficacy of the Carbocyclic 2′-Deoxyguanosine Nucleoside BMS-200475 in the Woodchuck Model of Hepatitis B Virus Infection

Por Genovesi, E. V., Lamb, L., Medina, I., Taylor, D., Seifer, M., Innaimo, S., Colonno, R. J., Standring, D. N., Clark, J. M.
Publicado em 1998